Results
|
1.
|
|
|
2.
|
|
|
3.
|
|
|
4.
|
|
|
5.
|
|
|
6.
|
|
|
7.
|
|
|
8.
|
|
|
9.
|
|
|
10.
|
|
|
11.
|
|
|
12.
|
|
|
13.
|
|
|
14.
|
Combined treatment of Nimotuzumab and rapamycin is effective against temozolomide-resistant human gliomas regardless of the EGFR mutation status. [electronic resource] by
- Chong, Dawn Q
- Toh, Xin Y
- Ho, Ivy A W
- Sia, Kian C
- Newman, Jennifer P
- Yulyana, Yulyana
- Ng, Wai-Hoe
- Lai, Siang H
- Ho, Mac M F
- Dinesh, Nivedh
- Tham, Chee K
- Lam, Paula Y P
Producer: 20160125
In:
BMC cancer vol. 15
Availability: No items available.
|
|
15.
|
Research needs for the risk assessment of health and environmental effects of endocrine disruptors: a report of the U.S. EPA-sponsored workshop. [electronic resource] by
- Kavlock, R J
- Daston, G P
- DeRosa, C
- Fenner-Crisp, P
- Gray, L E
- Kaattari, S
- Lucier, G
- Luster, M
- Mac, M J
- Maczka, C
- Miller, R
- Moore, J
- Rolland, R
- Scott, G
- Sheehan, D M
- Sinks, T
- Tilson, H A
Producer: 19970127
In:
Environmental health perspectives vol. 104 Suppl 4
Availability: No items available.
|